Syapse Expands Precision Medicine to Asia through Partnerships with Seoul National University Hospital and Megazone
Summary
Syapse and SNUH are launching a precision oncology program to improve cancer care in Korea, with the support of Megazones innovative cloud services. Syapses software enables oncologists to implement large-scale precision medicine by integrating the clinical, molecular, and outcomes data they need to make the most informed treatment decisions. "SNUH has long been on the cutting edge in both cancer care and technology, and Im thrilled to be partnering with them to help bring precision medicine to patients in South Korea." "Syapse give us a powerful platform to make effective cancer treatment decisions by using molecular analysis technology," said Kyung Hwan Kim, M.D., Thoracic and Cardiovascular Surgery, Chief Information Officer of SNUH. By bringing together leading healthcare innovators into a unified ecosystem, we are working toward a future in which all cancer patients have access to the best personalized care, regardless of location or income.
Classifications
AskAI Classifications
LabelsLinked Companies
